A Changing Natural History of HER2-positive Breast Cancer Metastatic to the Brain in the Era of New, Targeted Therapies

Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2017.07.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

The Role of HER2 in Early Breast Cancer Metastasis and the Origins of Resistance to HER2-targeted Therapies

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2009English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies

Clinical Cancer Research
Cancer ResearchOncology
2016English

New Developments in the Treatment of HER2-positive Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2012English

Prospective Evaluation of the Cardiac Safety of HER2-targeted Therapies in Patients With HER2-positive Breast Cancer and Compromised Heart Function: The SAFE-HEaRt Study

Breast Cancer Research and Treatment
Cancer ResearchOncology
2019English

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

Management of Toxicities Associated With Targeted Therapies for HR-positive Metastatic Breast Cancer: A Multidisciplinary Approach Is the Key to Success

Breast Cancer Research and Treatment
Cancer ResearchOncology
2019English

Metastatic Triple Negative Breast Cancer: Optimizing Treatment Options, New and Emerging Targeted Therapies

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy